Advertisement

Activity of Conventional Drugs in Head and Neck Cancer Xenografts

  • B. J. M. Braakhuis
  • G. B. Snow
Part of the ESO Monographs book series (ESO MONOGRAPHS)

Abstract

Nude mice bearing human head and neck cancer xenografts were treated with 5 anticancer drugs that are active in patients with this type of tumour. Using maximum tolerated dose levels, bleomycin appeared to be the most active drug, with activity in 4/9 lines tested; a growth delay factor of more than 2 (GDF>2) was taken as criterion of activity. 5-Fluorouracil and cyclophosphamide gave only moderate responses (1 <GDF<2) in 4/7 and 4/6 of the lines, respectively. Methotrexate and cisplatin, tested in 11 and 10 lines, respectively, were minimally or not active in the lines investigated. The activity of cisplatin appeared to be dose dependent. In the past higher doses could be given, resulting in 5/6 responding lines. In 4 lines a direct comparison could be made between the two schedules: lines that did not respond to treatment with the present schedule did so in the past, when the higher total dose was used. The activity of methotrexate in the nude mouse is less than can be expected from clinical studies. The mechanism responsible for this lack of activity is discussed in relation to our recent results.

Keywords

Nude Mouse Human Head Conventional Drug High Total Dose Nude Mouse Xenograft Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Braakhuis BJM, Sneeuwloper G and Snow GB: The potential of the nude mouse xenograft model for the study of head and neck cancer. Arch Otorhinolaryngol 1984 (239): 69–79PubMedCrossRefGoogle Scholar
  2. 2.
    Lindenberger J, Ganzer U and Fortmeyer HP: Die Heterotransplantation bösartiger Kopf-und Halsgeschwülste auf thymusaplastische nackte Mäuse. Arch Otorhinolaryngol 1978 (220): 117–128PubMedCrossRefGoogle Scholar
  3. 3.
    Wennerberg J, Tropé C and Biörklund A: Heterotransplantation of human head and neck tumours into nude mice. Acta Otolaryngol 1983 (95): 183–190PubMedCrossRefGoogle Scholar
  4. 4.
    Hill JH, Plant RL, Harris DM, Grossweiner LI, Rok B and Seter AJ: The nude mouse xenograft system: a model for photodetection and photodynamic therapy in head and neck squamous cell carcinoma. Am J Otolaryngol 1986 (7): 17–27PubMedCrossRefGoogle Scholar
  5. 5.
    Hong WK and Bromer R: Chemotherapy in head and neck cancer. N Engl J Med 1983 (308): 75–79PubMedCrossRefGoogle Scholar
  6. 6.
    Braakhuis BJM, Nauta MM, Romijn JC, Rutgers DH and Smink T: Enhanced success rate of transplantation with human tumors in cyclophosphamide-treated nude mice. J Natl Cancer Inst 1986 (76): 241–245PubMedGoogle Scholar
  7. 7.
    Braakhuis BJM, Leyva A, Schoevers EJ, Boerrigter GH, Schornagel JL and Snow GB: Lack of effect of methotrexate on human head and neck tumours transplanted in athymic nude mice. Acta Otolaryngol 1985 (99): 208–213PubMedCrossRefGoogle Scholar
  8. 8.
    Braakhuis BJM, Schoevers EJ, Heinerman ECM, Sneeuwloper G and Snow GB: Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cisplatinum, bleomycin and methotrexate. Br J Cancer 1983 (48): 711–716PubMedCrossRefGoogle Scholar
  9. 9.
    Wennerberg J, Alm P, Biörklund A, Killander D, Långström E and Tropé C: Cell cycle perturbations in heterotransplanted squamous cell carcinoma of the head and neck after mitomycin c and cisplatin treatment. Int J Cancer 1984 (33): 213–222PubMedCrossRefGoogle Scholar
  10. 10.
    Schornagel JH and McVie JG: The clinical pharmacology of methotrexate. Cancer Treat Rev 1983 (10): 53–75PubMedCrossRefGoogle Scholar
  11. 11.
    Jolivet J, Schilsky RL, Bailey BD, Drake JC and Chabner BA: Synthesis, retention and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. J Clin Invest 1982 (70): 351–360PubMedCrossRefGoogle Scholar
  12. 12.
    Fiebig HH, Schuchhardt C, Henss H, Fiedler L and Löhr GW: Comparison of tumor response in nude mice and in the patients. Behring Inst Mitt 1984 (74): 343–352PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • B. J. M. Braakhuis
    • 1
  • G. B. Snow
    • 1
  1. 1.Department of OtolaryngologyFree University HospitalAmsterdamThe Netherlands

Personalised recommendations